Skip to main content
Clinical Trials/CTRI/2020/06/025660
CTRI/2020/06/025660
Not yet recruiting
Phase 4

To Evaluate Analgesic efficacy of Dexmedetomidine as an adjuvant to Ropivacaine in USG Guided Erector Spinae Plane Block for Modified Radical mastectomy Surgery: A Prospective Randomised, Double blind Clinical study.

Department of Anaesthesiology Maharana Bhupal Government Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Anaesthesiology Maharana Bhupal Government Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Anaesthesiology Maharana Bhupal Government Hospital

Eligibility Criteria

Inclusion Criteria

  • ASA Grade I and II
  • Posted for Modified Radical Mastectomy surgery

Exclusion Criteria

  • Patient refusal
  • ASA Grade III and above
  • Drug allergy
  • Obese(BMI \>35 kg per sq.m)
  • Bradycardia
  • Coagulopathy
  • Cardiac Conduction Block
  • Infection at Injection site
  • patient n beta blocker or antiplatelet
  • Psychiatric illness

Outcomes

Primary Outcomes

Not specified

Similar Trials